You are here

Allarity Therapeutics

SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting

BioSpace

Tue, 07/23/24 - 11:32 am

Allarity Therapeutics

Amid CEO turmoil, Allarity loses rights to Novartis cancer drug over missed payments

Fierce Biotech

Fri, 02/2/24 - 11:57 am

Allarity Therapeutics

Allarity Therapeutics and Lonza to Develop and Manufacture Dovitinib

Contract Pharma

Thu, 09/23/21 - 10:37 pm

Allarity Therapeutics